SLC5A10: A Potential Drug Target for Diabetes (G125206)

Target Name: SLC5A10

NCBI ID: G125206

SLC5A10

SLC5A10: A Potential Drug Target for Diabetes

SLC5A10, also known as SLC5A10, is a protein that is expressed in various tissues throughout the body. It is a member of the Solute Carrier Family 5, which is a large family of transmembrane proteins that play a crucial role in the transport of various molecules across cell membranes. SLC5A10 is specifically involved in the transport of glucose across cell membranes, and its function in this process has been extensively studied.

SLC5A10 is a transmembrane protein that is composed of four polypeptide chains. It consists of an N-terminus that is involved in interactions with various cellular signaling pathways, a catalytic center that is responsible for glucose transport, and two C-terminus that are involved in its interactions with other proteins. SLC5A10 is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys.

SLC5A10's function in glucose transport is critical for maintaining proper cellular metabolism. Glucose is the body's primary source of energy, and it is essential for the survival of all living organisms. glucose is transported across cell membranes using a specialized protein called carrier, which is involved in the transport of various molecules across the membrane. SLC5A10 is one of the most well-studied vector expression regulators, and its function in this process is crucial for the proper functioning of the cell.

SLC5A10 has been extensively characterized for its role in glucose transport. Several studies have shown that SLC5A10 plays a critical role in the uptake and internalization of glucose across cell membranes. These studies have shown that SLC5A10 is involved in the formation of glucose transport complexes, which are responsible for the transport of glucose across the membrane. SLC5A10 has also been shown to play a role in the regulation of glucose uptake and storage.

In addition to its role in glucose transport, SLC5A10 has also been shown to be involved in the regulation of various cellular processes. For example, several studies have shown that SLC5A10 is involved in the regulation of cell adhesion, and its expression has been shown to be regulated by various signaling pathways. SLC5A10 has also been shown to be involved in the regulation of cell proliferation and apoptosis, and its expression has been shown to be regulated by various signaling pathways.

SLC5A10 is also a potential drug target in the field of diabetes. Its role in glucose transport and regulation of various cellular processes makes it an attractive target for the development of new diabetes treatments. Several studies have shown that SLC5A10 is involved in the regulation of insulin sensitivity and its expression has been shown to be regulated by various signaling pathways. Therefore, targeting SLC5A10 with drugs that can modulate its expression and function could be an effective way to treat diabetes.

In conclusion, SLC5A10 is a transmembrane protein that is involved in the transport of glucose across cell membranes. Its function in this process is critical for maintaining proper cellular metabolism, and its regulation by various signaling pathways makes it an attractive target for the development of new diabetes treatments. Further research is needed to fully understand the role of SLC5A10 in glucose transport and its potential as a drug target.

Protein Name: Solute Carrier Family 5 Member 10

Functions: Electrogenic Na+-coupled sugar symporter that actively transports D-mannose or D-fructose at the plasma membrane, with a Na+ to sugar coupling ratio of 1:1. Transporter activity is driven by a transmembrane Na+ electrochemical gradient set by the Na+/K+ pump. Exclusively recognizes sugar substrates having a pyranose ring with an axial hydroxyl group on carbon 2 (PubMed:24573086, PubMed:22212718, PubMed:23451068). Has likely evolved to enable renal reabsorption of D-mannose, an important constituent of oligosaccharide chains of glycoproteins. Contributes to dietary D-fructose reabsorption from glomerular filtrate across the brush border of the kidney (PubMed:22212718, PubMed:23451068)

The "SLC5A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC5A10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets